Xeloxiri as First-line Treatment in Patients With Advanced Unresectable Pancreatic Adenocarcinoma
Clinical trial NCT01558869 · COMPLETED
Trial details
- NCT number
- NCT01558869
- Sponsor
- The University of Hong Kong
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2016-12-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.